Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription


4 Ann Oncol
1 Ann Surg Oncol
5 Cancer Lett
5 Cancer Res
2 Clin Cancer Res
1 Eur J Cancer
1 Gastroenterology
2 Hum Pathol
3 Int J Cancer
4 J Natl Cancer Inst
1 J Nucl Med
1 J Pathol
1 Oncogene
8 PLoS One
2 World J Surg

    Ann Oncol

  1. NORMANNO N, Esposito Abate R, Lambiase M, Forgione L, et al
    RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial.
    Ann Oncol. 2017 Aug 7. doi: 10.1093.
    >> Share

  2. GARCIA-FONCILLAS J, Alba E, Aranda E, Diaz-Rubio E, et al
    Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review.
    Ann Oncol. 2017 Sep 4. doi: 10.1093.
    >> Share

  3. SIENA S, Sartore-Bianchi A, Garcia-Carbonero R, Karthaus M, et al
    Dynamic Molecular Analysis and Clinical Correlates of Tumor Evolution Within a Phase 2 Trial of Panitumumab-Based Therapy in Metastatic Colorectal Cancer.
    Ann Oncol. 2017 Sep 4. doi: 10.1093.
    >> Share

  4. SCIALLERO S, Battistuzzi L, Varesco L
    Including Lynch syndrome in personalized prognostication and follow-up of stage II and III colon cancer.
    Ann Oncol. 2017;28:2620-2621.
    >> Share

    Ann Surg Oncol

  5. CLARKE CN, Lee MS, Wei W, Manyam G, et al
    Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
    Ann Surg Oncol. 2017 Sep 21. doi: 10.1245/s10434-017-6054.
    >> Share

    Cancer Lett

  6. WESTDORP H, Kolders S, Hoogerbrugge N, de Vries IJM, et al
    Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome.
    Cancer Lett. 2017;403:159-164.
    >> Share

  7. RADHAKRISHNAN H, Ilm K, Walther W, Shirasawa S, et al
    MACC1 regulates Fas mediated apoptosis through STAT1/3 - Mcl-1 signaling in solid cancers.
    Cancer Lett. 2017;403:231-245.
    >> Share

  8. LI W, Qiu T, Guo L, Ying J, et al
    Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing.
    Cancer Lett. 2017 Sep 21. pii: S0304-3835(17)30564.
    >> Share

  9. YAGDI EFE E, Mazumder A, Lee JY, Gaigneaux A, et al
    Tubulin-binding anticancer polysulfides induce cell death via mitotic arrest and autophagic interference in colorectal cancer.
    Cancer Lett. 2017 Sep 21. pii: S0304-3835(17)30561.
    >> Share

  10. FANG C, Qiu S, Sun F, Li W, et al
    Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA.
    Cancer Lett. 2017 Sep 21. pii: S0304-3835(17)30562.
    >> Share

    Cancer Res

  11. VISWANATHAN V, Damle S, Zhang T, Opdenaker LM, et al
    An miRNA expression signature for the human colonic stem cell niche distinguishes malignant from normal epithelia.
    Cancer Res. 2017 May 9. pii: canres.2388.2016.
    >> Share

  12. MARELLI G, Erreni M, Anselmo A, Taverniti V, et al
    Heme-oxygenase-1 Production by Intestinal CX3CR1+ Macrophages Helps to Resolve Inflammation and Prevents Carcinogenesis.
    Cancer Res. 2017;77:4472-4485.
    >> Share

  13. ZHAO Y, Ting KK, Li J, Cogger VC, et al
    Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell-Mediated Immunotherapy.
    Cancer Res. 2017;77:4434-4447.
    >> Share

  14. JERMYN M, Mercier J, Aubertin K, Desroches J, et al
    Highly Accurate Detection of Cancer In Situ with Intraoperative, Label-Free, Multimodal Optical Spectroscopy.
    Cancer Res. 2017;77:3942-3950.
    >> Share

  15. ZHOU X, Geng L, Wang D, Yi H, et al
    R-Spondin1/LGR5 Activates TGFbeta Signaling and Suppresses Colon Cancer Metastasis.
    Cancer Res. 2017 Sep 22. pii: canres.0219.2017.
    >> Share

    Clin Cancer Res

  16. KANG DW, Lee BH, Suh YA, Choi YS, et al
    Phospholipase D1 inhibition linked to upregulation of ICAT blocks colorectal cancer growth hyperactivated by Wnt/beta-catenin and PI3K/Akt Signaling.
    Clin Cancer Res. 2017 Sep 22. pii: clincanres.0749.2017.
    >> Share

  17. JOUNG JG, Oh BY, Hong HK, AlKhalidi H, et al
    Tumor heterogeneity predicts metastatic potential in colorectal cancer.
    Clin Cancer Res. 2017 Sep 22. pii: clincanres.0306.2017.
    >> Share

    Eur J Cancer

  18. MALKA D, Rotolo F, Boige V
    First-line treatment in metastatic colorectal cancer: Important or crucial?
    Eur J Cancer. 2017;84:363-366.
    >> Share


  19. GIES A, Cuk K, Schrotz-King P, Brenner H, et al
    Direct Comparison of Diagnostic Performance of 9 Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening.
    Gastroenterology. 2017 Sep 25. pii: S0016-5085(17)36177.
    >> Share

    Hum Pathol

  20. CAPPELLESSO R, Luchini C, Veronese N, Lo Mele M, et al
    Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: a meta-analysis.
    Hum Pathol. 2017;65:62-70.
    >> Share

  21. LINO-SILVA LS, Salcedo-Hernandez RA, Espana-Ferrufino A, Ruiz-Garcia EB, et al
    Extramural perineural invasion in pT3 and pT4 rectal adenocarcinoma as prognostic factor after preoperative chemoradiotherapy.
    Hum Pathol. 2017;65:107-112.
    >> Share

    Int J Cancer

  22. TANSKANEN T, van den Berg L, Valimaki N, Aavikko M, et al
    Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci.
    Int J Cancer. 2017 Sep 28. doi: 10.1002/ijc.31076.
    >> Share

  23. PAN R, Zhu M, Yu C, Lv J, et al
    Cancer incidence and mortality: A cohort study in China, 2008-2013.
    Int J Cancer. 2017;141:1315-1323.
    >> Share

  24. VARGAS-PARRA GM, Gonzalez-Acosta M, Thompson BA, Gomez C, et al
    Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
    Int J Cancer. 2017;141:1365-1380.
    >> Share

    J Natl Cancer Inst

  25. HANLEY CJ, Mellone M, Ford K, Thirdborough SM, et al
    Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4.
    J Natl Cancer Inst. 2018;110.
    >> Share

  26. JOHNSON SB, Park HS, Gross CP, Yu JB, et al
    Use of Alternative Medicine for Cancer and Its Impact on Survival.
    J Natl Cancer Inst. 2018;110.
    >> Share

  27. MLECNIK B, Van den Eynde M, Bindea G, Church SE, et al
    Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
    J Natl Cancer Inst. 2018;110.
    >> Share

  28. MARISA L, Svrcek M, Collura A, Becht E, et al
    The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors.
    J Natl Cancer Inst. 2018;110.
    >> Share

    J Nucl Med

  29. BOAS FE, Bodei L, Sofocleous CT
    Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes.
    J Nucl Med. 2017;58.
    >> Share

    J Pathol

  30. SHU XS, Zhao Y, Sun Y, Zhong L, et al
    PBRM1 restricts the basal activity of innate immune system through repressing RIG-I-like receptor signaling and is a potential prognostic biomarker for colon cancer.
    J Pathol. 2017 Sep 20. doi: 10.1002/path.4986.
    >> Share


  31. FU LN, Wang YQ, Tan J, Xu J, et al
    Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    >> Share

    PLoS One

  32. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    >> Share

  33. HENNENBERG EM, Eyking A, Reis H, Cario E, et al
    MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis.
    PLoS One. 2017;12:e0180834.
    >> Share

  34. HOCHMAN G, Halevi-Tobias K, Kogan Y, Agur Z, et al
    Extracellular inhibitors can attenuate tumorigenic Wnt pathway activity in adenomatous polyposis coli mutants: Predictions of a validated mathematical model.
    PLoS One. 2017;12:e0179888.
    >> Share

  35. HILSDEN RJ, Bridges R, Dube C, Heitman SJ, et al
    Scheduling rules for patients with diabetes mellitus that facilitate split-dosing improve the quality of bowel preparation for colonoscopy.
    PLoS One. 2017;12:e0182225.
    >> Share

  36. XU R, Lin L, Li Y, Li Y, et al
    ShenQi FuZheng Injection combined with chemotherapy in the treatment of colorectal cancer: A meta-analysis.
    PLoS One. 2017;12:e0185254.
    >> Share

  37. SLIK K, Kurki S, Korpela T, Carpen O, et al
    Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer.
    PLoS One. 2017;12:e0185436.
    >> Share

  38. NIIKURA R, Hirata Y, Suzuki N, Yamada A, et al
    Colonoscopy reduces colorectal cancer mortality: A multicenter, long-term, colonoscopy-based cohort study.
    PLoS One. 2017;12:e0185294.
    >> Share

  39. COEBERGH VAN DEN BRAAK RRJ, Sieuwerts AM, Kandimalla R, Lalmahomed ZS, et al
    High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.
    PLoS One. 2017;12:e0185607.
    >> Share

    World J Surg

  40. BELLIER J, De Wolf J, Hebbar M, Amrani ME, et al
    Repeated Resections of Hepatic and Pulmonary Metastases from Colorectal Cancer Provide Long-Term Survival.
    World J Surg. 2017 Sep 25. doi: 10.1007/s00268-017-4265.
    >> Share

  41. SEO GH, Choe EK, Park KJ, Chai YJ, et al
    Incidence of Clinically Relevant Incisional Hernia After Colon Cancer Surgery and Its Risk Factors: A Nationwide Claims Study.
    World J Surg. 2017 Sep 27. doi: 10.1007/s00268-017-4256.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016